Home-Monitoring in Implantable Cardioverter Defibrillator (ICD) Patients

Home-Monitoring in ICD Patients

The purpose of this study is to investigate the cost-effectiveness and effectiveness of remote-monitoring compared to standard care in patients with implantable cardioverter defibrillator.

Implantable cardioverter defibrillator (ICD) are an important and effective treatment in patients at risk of sudden cardiac death. In order to allow for a more continuous follow-up and reduced complication rates of patients with ICD, new devices including remote-monitoring (home-monitoring) features of patients with ICD have been developed. BIOTRONIK Home Monitoring service enables the doctors to safely follow up their patients with implanted cardioverter-defibrillators in a remote fashion, with fewer in-clinic consultations. This may result in a more efficient follow-up and cost-savings for the health care payer.

The objective of the current study is to investigate the cost-effectiveness and effectiveness of home-monitoring compared to standard care.

Inclusion Criteria:

• The patient is willing/able to undergo the study protocol appointments and procedures/questionnaires
• Indication for implantation of single chamber ICD or dual chamber ICD according to European guidelines

Exclusion Criteria:

• Age < 18 and > 80 years
• Expected non-compliance
• Known drug or alcohol abuse
• Life expectancy < 1 year
• NYHA classification IV
• Participation in another clinical study
• Participation in another telemonitoring concept
• Pregnant or breast-feeding woman
• Uncontrolled hypertension
• No mobile phone use possible in patient residence